Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) of the indole-acetic acid derivative class, used primarily to reduce inflammation, pain, fever, and swelling. It is indicated for the symptomatic treatment of moderate to severe pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, bursitis and tendinitis of the shoulder. It is also used in certain headache disorders (such as paroxysmal hemicrania and hemicrania continua) and for closure of patent ductus arteriosus in premature infants. Its mechanism of action involves potent nonselective inhibition of cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins that mediate inflammation and pain[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indomethacin.